top of page
I believe drug names matter, and I have helped companies develop hundreds of names, including Perjeta®, Spiolto®, Flixabi®, Enbrel®, Celebrex® and Viagra®.
I have written about naming in, and have been covered by,
The New York Times, Advertising Age, The Boston Globe, BBC News Magazine, LinkedIn Pulse, and NPR Radio.
bottom of page